Fig. 1From: Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot studyBox plots representing the behaviour of flow-mediated dilation (a), pulse wave velocity (b) and resting renal resistive index (c) in the study population before (in white) and after (in grey) 2-day treatment with dapagliflozin or hydrochlorothiazideBack to article page